Literature DB >> 11401941

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.

G Caligiuri1, M Rottenberg, A Nicoletti, H Wigzell, G K Hansson.   

Abstract

BACKGROUND: Seroepidemiological studies have linked Chlamydia pneumoniae (CP) to coronary heart disease, and recent experimental studies suggest that it may accelerate or even induce atherosclerosis. We therefore evaluated the effect of CP infection on atherosclerosis in atherosclerosis-prone apolipoprotein E-knockout (apoE-KO) and wild-type C57BL/6J mice. METHODS AND
RESULTS: Six- to 8-week-old female mice were infected intranasally with live CP and then fed a standard chow diet for 22 weeks. A subgroup of mice was reinfected 18 weeks after primary infection. Polymerase chain reaction analysis of lung tissue confirmed successful infection with CP, and ELISA assays demonstrated development of a humoral immune response. Despite this, no statistically significant differences in aortic atherosclerotic lesions were found between CP-infected and control apoE-KO mice. Furthermore, CP infection did not induce atherosclerosis in C57BL/6J mice.
CONCLUSIONS: CP does not induce atherosclerosis in wild-type mice and does not accelerate atherosclerosis in chow-fed apoE-KO mice. Further studies will be necessary to clarify the explanation for the seroepidemiological association between CP and coronary heart disease in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401941     DOI: 10.1161/01.cir.103.23.2834

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

2.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 3.  Toll-like receptors and atherosclerosis: key contributors in disease and health?

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Chronic infections and atherosclerosis/thrombosis.

Authors:  Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

5.  Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.

Authors:  G Arno; J C Kaski; D A Smith; J P Akiyu; S E Hughes; C Baboonian
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

6.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.

Authors:  Victoria L M Herrera; Li Shen; Lyle V Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

8.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Authors:  Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L Telford; Cosima T Baldari; Sergio Romagnani; Antonio Cassone; Mario M D'Elios; Gianfranco Del Prete
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

Review 9.  Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome.

Authors:  Kenichi Shimada; Timothy R Crother; Moshe Arditi
Journal:  Microbes Infect       Date:  2012-09-05       Impact factor: 2.700

10.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.